Search results
Found 6830 matches for
Oxford University, through its innovation arm Oxford University Innovation (OUI), has entered into an option agreement for a universal influenza vaccine with US-based startup Blue Water Vaccines (BWV), which is raising $15m to support development of the flu shot.
Glowing dye helps surgeons eradicate prostate cancer
General Research
11 June 2024
A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study led by the University of Oxford.
Sildenafil (‘Viagra’) improves brain blood flow and could help to prevent dementia
General Research
10 June 2024
A new trial conducted by the University of Oxford reveals that sildenafil, commonly known as Viagra, enhances blood flow to the brain and improves the function of brain blood vessels in patients at a heightened risk of vascular dementia.
PRINCIPLE and PANORAMIC teams honoured with prestigious Prix Galien Award
Awards and Appointments General
3 June 2024
The teams behind the PRINCIPLE and PANORAMIC clinical trials, run in the Clinical Trials Unit at the Nuffield Department of Primary Care Health Sciences, have been awarded the prestigious Prix Galien Best Public Sector Innovation Award 2024 for their work in conducting innovative, large-scale clinical trials during the COVID-19 pandemic.
New small molecule found to suppress the evolution of antibiotic resistance in bacteria
General Research
28 May 2024
Researchers from the Ineos Oxford Institute for antimicrobial research (IOI) and the Department of Pharmacology at Oxford University, have developed a new small molecule that can suppress the evolution of antibiotic resistance in bacteria and make resistant bacteria more susceptible to antibiotics.
University of Oxford research receives £5 million funding boost from British Heart Foundation
General Research
24 May 2024
Funding will support world-leading cardiovascular disease research.
Hiding in plain sight: study identifies cryptic disease-causing genetic variants not detected by standard testing
General Research
23 May 2024
Researchers in Oxford have identified types of genetic variants that lead to a range of rare disease but are not picked up by standard genetic testing.
Safety Network Newsletter issue 8
22 May 2024
Transformative solutions to antibiotic resistance
General Research
21 May 2024
More than 1.2 million people die each year as a direct result of antibiotic-resistant bacterial infections. But this number could soon rise dramatically: as resistance spreads, an increasing number of infections are becoming harder – and sometimes impossible – to treat as antibiotics become less effective.
Academy of Medical Sciences elects eight Oxford researchers as new Fellows
Awards and Appointments General
21 May 2024
The Academy of Medical Sciences has elected eight University of Oxford biomedical and health scientists to its fellowship in 2024.
New Maternity Early Warning Score to be implemented across the NHS
General Research
20 May 2024
Researchers in Oxford have developed a new maternity early warning score that is derived from patient data. The new system, which is being rolled out across the English NHS, will help healthcare providers identify and respond to signs of deterioration in pregnant women
Early blood glucose control for people with type 2 diabetes is crucial for reducing complications and prolonging life
General Research
20 May 2024
Research led by scientists from the Universities of Oxford and Edinburgh has found that early good blood glucose control can minimise the lifetime risk of diabetes-related complications, including heart attacks, kidney failure and vision loss.
Nine Oxford scientists elected as Royal Society Fellows
Awards and Appointments General
17 May 2024
Nine academics from the University of Oxford, including four from the Medical Sciences Division, have joined the Royal Society as Fellows
World hypertension day: How we’re tackling high blood pressure from pregnancy to later life
General Research
17 May 2024
For World Hypertension Day 2024, discover three of our innovative studies – SNAP2, SHIP, and OPTIMISE 2 – aiming to improve blood pressure management across the life cycle through technology and patient involvement.
Cancer Cell study identifies possible ways cancer treatment can lead to harmful side effects
General Research
16 May 2024
Researchers from the Simmons and Koohy Groups in the Weatherall Institute of Molecular Medicine (WIMM) Translational Immune Discovery Unit have identified potential pathways by which cancer treatment can cause colitis.
Internet use statistically associated with higher wellbeing, finds new global Oxford study
General Research
15 May 2024
Links between internet adoption and wellbeing are likely to be positive, despite popular concerns to the contrary, according to a major new international study from researchers at the Oxford Internet Institute, part of the University of Oxford.
Update on Council Vacancies – MSD Candidates
14 May 2024
Medical Sciences celebrates success at Vice-Chancellor’s Awards 2024
Awards and Appointments General
14 May 2024
The Vice-Chancellor Professor Irene Tracey, CBE FRS FMedSci, presented the awards at a special ceremony at the Sheldonian Theatre.